Breast cancer metastasis - insight into selected molecular mechanisms of the phenomenon

Jarosław Kozłowski1, Aleksandra Kozłowska2, Janusz Kocki3

  • 1Department of Clinical Genetics, Medical University of Lublin; Department of Oncological Surgery, St. John's Cancer Center, Lublin.

Insights

Metastasis, the spread of breast cancer, remains a major challenge despite treatments. Understanding its complex mechanisms is crucial for developing better therapies to combat cancer progression and improve patient outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Breast cancer treatment advances control primary tumors but struggle with metastatic disease.
  • Metastatic breast cancer remains a significant global health problem with high incidence and mortality.
  • Current understanding of metastasis mechanisms is incomplete, hindering effective long-term control.

Purpose of the Study:

  • To review key aspects of the breast cancer metastatic cascade.
  • To highlight molecular and cellular interactions driving metastasis.
  • To introduce biomolecules and genes involved in breast cancer progression.

Main Methods:

  • Review of existing literature on breast cancer metastasis.
  • Analysis of the metastatic cascade, including dissemination models.
  • Discussion of tumor angiogenesis, cell migration, and organotropism.

Main Results:

  • Metastasis is a multistep process involving numerous genes and biomolecules.
  • Interactions between cancer cells and host cells are critical.
  • Factors like angiogenesis, cell migration, and organotropism facilitate spread.

Conclusions:

  • Further research into breast cancer metastasis mechanisms is essential.
  • Improved understanding will inform novel therapeutic strategies.
  • Targeting metastatic pathways offers potential for better breast cancer management.

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
7.0K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.6K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
8.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.5K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
11.0K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.6K